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Does routine measurement of ankle brachial index ameliorates the
assessment of coronary risk level in patients with known or suspected
coronary artery disease. The ABICARD study
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Ducher (1), Xavier André-Fouët (1), Denis Angoulvant (1)
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Lyon Cedex 03, France – (2) Inserm, CIC 201 Hospices Civils de Lyon,
Lyon, France – (3) Inserm U886 – Université Claude Bernard Lyon 1,
Physiologie Lyon Nord, Lyon Cedex 08, France
Background: Ankle-brachial pressure index (ABI) is an independent pre-
dictor of the extent of coronary atherosclerosis and cardiovascular events. To
date ABI measurement is not part of the routine examination in patient
admitted for coronary angiography. Our objective was to establish ABI measu-
rement as a routine procedure in our interventional cardiology unit to amelio-
rate the assessment of coronary risk level for patients admitted for scheduled
coronary angiography. 
Method: ABI measurement was performed on admission using a doppler ultra-
sonic instrument. Patients with past medical history of peripheral arteriopathy were
excluded. Cardiovascular risk factors and clinical findings were collected. Correla-
tions and multivariate analysis were performed on R software. 
Results: In the pilot study, 40 consecutive patients were included between
February and April 2009. 79% were males and the mean age was 66+/-12 years.
ABI < 0.9 was found in 6 patients. Significant multivessel disease was found in
10 patients: 6 with ABI<0.9 and 4 with ABI≥0.9. Patients with ABI<0.9 were
significantly older 75+/-11 vs 64+/-12 (p=0.04) and had a trend for lower glo-
merular filtration rate MDRD=61+/-21 vs 77+/-20 mL/min/1.73m_ (p=0.08). 5-
years probability of cardiovascular death was 12+/-7.4% in patients with
ABI<0.9 vs 7.2+/-7.6 in patients with ABI≥0.9 (p=ns). Multivariate analysis
showed that ABI remains a significant predictor of multivessel disease after
adjustment on other risk factors. Low ABI was significantly correlated with 5
years probability of cardiovascular death (spearman = -0.36, P=0.03). 
Conclusion: ABI was an independent predictor of coronary multivessel
disease and 5 years probability of cardiovascular death. Routine ABI measu-
rement in patients with known or suspected coronary artery disease provides
additional information regarding patient’s risk and may be taken into account
to establish optimal care strategy.
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Natural History Of Dual Anti-Platelet Responsiveness After Angio-
plasty In Elderly Patients
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Background: Dual antiplatelet therapy with aspirin (Asa) and clopido-
grel (Clopi) is the cornerstone of treatment for patients (pts) after angioplasty
(PCI). The state of dual antiplatelet responsiveness is not well known espe-
cially in elderly pts.
Objectives: The aim of this monocentric prospective observational study is
to evaluate Asa and Clopi activity after PCI in elderly pts and to asses the evo-
lution of this responsiveness at 5 weeks.
Methods: We enrolled 81 elderly pts (≥75 years) from Jan to Dec 2008
on Asa (75 mg/day ≥ 7 days) and Clopi (after loading dose 300 mg before PCI
and 150mg /day for 4 weeks fellowed by 75 mg/ day for 1 year). We used the
VerifyNow Asa assay and the VerifyNow Clopi P2Y12 assay (Accumetrics
Inc, USA) to determinate respectively Asa and Clopi responsiveness in-hos-
pital at 11.30 am (T1) and during a medical consultation at 5 weeks (T2).
Results: Asa non responders were noted in 10% and in 14% pts at respec-
tively T1 and T2, Clopi non responders in 37% and in 70% pts at respectively
T1 and T2. Significant changes were observed in Clopi response from res-
ponder to non responder (p < 0.001); similarly changes were noticed but in
both ways for Asa response from T1 to T2 (p=0.005). Mutivariate analysis
revelead plasma-HDL-cholesterol (OR [0.81]; 95% CI[0.67 to 0.98];p=0.031;
for a raising of 0.1 mmol/L) and hematocrit level (OR [0.85]; 95% CI [0.75 to
0.96]; p=0.008 for an increasing of 1%) to be independent predictors of Clopi
non responsiveness at T1; in the same way diabetes (OR [0.30]; 95% CI [0.10
to 0.95]; p=0.041; for non diabetes vs diabetes) and hematocrit level (OR
[0.8]; 95% CI [0.77 to 1.00]; p=0.045 for an increasing of 1%) are independtly
associated with Clopi non responsiveness at T2.
Conclusions: In elderly, after PCI, there are changes in dual antiplatelet
responsiveness between tests in-hospital and at 5 weeks marked for Clopi acti-
vity. Low hematocrit remains an independent predictor of Clopi non responsi-
veness.
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Predictive factors of ST-segment resolution after primary angioplasty
and clinical outcome
Khaldoun Ben Hamda, Feriel Moatemri, Hichem Denguir, Sonia Hamdi,
Mohamed Amine Majdoub, Sabri Maaoui, Hamza Thawaba, Faouzi Maa-
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In the setting of acute myocardial infarction (AMI), early resolution of ST-
segment elevation was a useful predictor of final infarct size, left ventricular
function and clinical outcome.
Aim: to determine the predictive factors of ST-segment resolution imme-
diately following primary coronary angioplasty for AMI.
Methods: primary angioplasty was performed in 270 consecutive patients
with first AMI, they were divided into 2 groups according to whether ST-seg-
ment resolution occurred 1 hour after the procedure. ST-segment resolution ≥
70% was considered as ‘complete’ ST-segment resolution, whereas ST-seg-
ment resolution < 70% was considered as ‘incomplete’ ST-segment resolution.
Results: of the 270 patients, 156 (57.8%) had complete ST-segment reso-
lution. Patients with pre-infarction angina had a greater degree of ST-segment
resolution than those without angina (71 ±21 % vs. 49± 43%, p<0.02).
On multivariate analysis, the absence of pre-infarction angina (OR=2.7; CI
1.7-3.4,p=0.03) as well as the admission after H4 (OR=3.5; CI 1.58-8.06,
p=0.002), patient age ≥ 70 year(OR= 5.6; CI 2.23-14.4,p<0.001) and initial
TIMI flow grade 0/1 (OR=13.6; CI 4.5-21.2, p<0.001) were major indepen-
dent predictors of poor ST-segment resolution; whereas sex, coronary risk fac-
tors, killip class on admission, multivessel disease and extent of collaterals
were not significant.
There was a significant difference in survival free of major adverse cardio-
vascular events, at multivariate analysis =, incomplete ST-segment resolution
was an independent factor of 1-year mortality (p=0.016).
Conclusions: Rapid ST-segment resolution was associated with a better
clinical outcome and prognosis after successful primary PTCA. Pre-infarction
angina, age < 70 years, TIMI flow 2/3 and ischemia time < 4 hours were asso-
ciated with a greater degree of ST-segment resolution after primary angio-
plasty.
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C-Reactive Protein Improves Risk Prediction in Patients with Acute
Coronary Syndromes
Francois Schiele, Nicolas Meneveau, Marie-France Seronde, Vincent Des-
cotes-Genon, Romain Chopard, Joanna Oettinger, Alexandre Guignier,
Florant Briand, Jean-Pierre Bassand
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Rationale and aim: Elevated C-reactive protein level is a risk marker in
patients with acute coronary syndromes (ACS), but current risk score systems
do not consider this factor. We studied the incremental predictive value of
adding CRP to the GRACE risk score.
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Methods and results: Characteristics, treatments and 30-day mortality were
recorded for 1408/1901 consecutive ACS patients. Changes in global model fit,
discrimination, calibration and reclassification were evaluated upon addition of
CRP to the GRACE risk score. High-CRP patients (CRP >22 mg/L, 4th quartile of
CRP) were older, had more comorbidities and worse hemodynamic conditions,
received less recommended treatment and had a four-fold higher 30 day mortality.
Multivariable analysis demonstrated high-CRP as an important and independent
predictor of mortality. Addition of high-CRP in the GRACE model improved
global fit, discriminatory capacity and calibration. Patients were divided into 4
groups according to GRACE risk score prediction: <1%, 1 to <5%, 5 to <10% and
>=10%. The model with high-CRP allowed adequate reclassification in 12.2%.
Conclusions: Elevated CRP level is an independent and important predic-
tive factor of 30-day mortality in ACS patients, even after adjustment for co-
morbidities, hemodynamic conditions and treatment. Combined with the
GRACE risk score, CRP information improves risk classification.
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Coronary angioplasty of the chronic total occlusion. Outcome and
study of the Balance Risc and Benefit. A study of 62 cases
Kais Battikh, Maher Souissi, M Lotfi Slimane
CHU Habib Thameur Tunis, Cardiologie, Tunis, Tunisie
Percutaneous coronary intervention (PCI) of the coronary chronic total
occlusion (CTO) is widely discussed because of the difficulty and the risks of
the procedure and the controversial but very interesting clinical benefit in case
of procedure success.
Objective: To evaluate the in-hospital and long-term clinical outcome of
PCI in the case of CTO and measure the adverse effects and complications.
Methods: 62 cases of PCI for a CTO were consecutively registered from
January 2005 to February 2009. In addition to an assessment of the technical
characteristics and procedural outcomes, patients were followed for occurrence
of major adverse cardiac events (MACE). These patients are distributed in two
groups: (A) for the occlusion between 1 and 3 months age and (B) for the occlu-
sion of more than 3 months age. RESULTS: 68 lesions were treated in these 62
patients (47 male and 15 female) with mean age of 59 years (40-80). 42% of
theses patients were diabetics, 48% smoker and 26% with hypertension. 27
patients had an ST elevation acute coronary syndrome (ACS) and 24 a non ST
elevation ACS, where 2 had stable angina. Balloon angioplasty was performed
in only 4 cases and the stenting in 58 cases with use of 64 stents (average of 1.1
stent / artery and of 1.2 stent / patient), we used drug eluting stent in only 10
case (15.6 %). Total procedure success rate, defined by a patent artery (less then
30% residual stenosis) with TIMI 3 flow (grade 3) at the end of the PCI was 83
%( 57/68) . The success was better in the group A 90% (29/32) then the group
B 77% (28/36) (P < 0.05). The most frequent cause of procedure failures was
unsuccessful crossing with the wire in 6 cases and no severe acute complications
were done. Theses CTO required long procedures with an average time of fluo-
roscopy of 30 ’ 13 ", an average calculated dose radiation DAP of 20611 cGy /
cm2 and a high mean amount of contrast media 289.46 ml. At the preliminary
clinical results, patients with successful PCI of a CTO had a significantly better
clinical outcome than those whose PCI was unsuccessful.
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Does heart rate predict coronary allograft vasculopathy and coronary
events in heart transplant recipients?
Pierre Ambrosi (1), Gilbert Habib (1), Bernard Kreitmann (2)
(1) Hôpital de la Timone, Service de Cardiologie, Marseille, France – (2)
Hôpital de la Timone, Chirurgie cardiaque, Marseille, France
Previous studies have shown that heart rate is a predictor of coronary
events and cardiovascular mortality. Moreover, pathophysiological studies
indicate that a relatively high heart rate has detrimental effects on the progres-
sion of coronary atherosclerosis. Heart transplant recipients frequently have
sinus tachycardia related to cardiac denervation. Therefore we evaluated the
prognostic importance of heart rate in heart transplant recipients.
143 consecutive heart transplant recipients (age at transplantation: 48.5±13
years) with at least a 2 year survival after transplantation were studied with a
9.5 year mean follow-up (range 2-23 years). Basal heart rate was measured at
rest 3 months after heart transplantation in the absence of beta-blocker therapy
or acute rejection. Survival without cardiac event was compared between
patients with basal heart rate < or >95/min (median) according to Kaplan-
Meier method using log-rank test.
Fifty-six patients had coronary irregularities or stenoses at routine biennal
coronary angiography and 87 had angiographically normal coronary arteries
during the follow-up. Mean basal heart rate did not significantly differ between
these two groups (96.4/min vs 98.3/min p=0.34). Twenty-seven patients had a
coronary event (myocardial infarction, percutaneous coronary intervention or
coronary death). Survival without coronary event did not significantly differ
between patients with basal heart rate > or < 95/min (logrank p= 0,97).
Conclusion: This series does not support a prognostic influence of heart
rate for cardiac allograft vasculopathy or coronary events in heart transplant
recipients.
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Marked reduction of operator radiation exposure by using a patient
lead cover during coronary angiography or percutaneous intervention
Bogdan Radulescu (1), Pauline Bouyer (2), Luc Mertz (2), Olivier Morel
(1), Michel Zupan (1), Pierre Bareiss (1), François Bronner (1), André
Constantinesco (2), Patrick Ohlmann (1)
(1) Hôpitaux Universitaires de Strasbourg, Pôle cardiovasculaire, Stras-
bourg, France – (2) Hôpitaux Universitaires de Strasbourg, Médecine
nucléaire, Strasbourg, France
Background: Operators and patient radiation exposure during interven-
tional cardiology procedures may induce radiation injury and may increase
risk of cancer.
Objectives: To determine the effectiveness of a lead cover placed over the
patient abdomen and groins in reducing operator radiation exposure during
coronary intervention.
Methods: Radiation exposure measurements were performed over an 8
weeks period, in patients undergoing diagnostic and/or interventional coronary
procedures. Usual protection of the operator was ensured using a lead apron, low
leaded flaps, and leaded glass. Each of three procedures was realized using a
lead cover placed on the patient abdomen. Operator irradiation was assessed by
using 3 electronic dosimeters placed over the apron on the chest and in the back
(no 1, 2) on the left arm (no 3). Patient radiation exposure (using the diamentor
system), ambiental irradiation (using an electronic dosimeter placed in the room
opposite to the Xray tube) and fluoroscopy times were recorded. Results are pre-
sented in mean ± SEM and comparisons assessed by student t test.
Results: Operator exposure was assessed during 189 procedures (136 coronary
angiograms and 53 percutaneous coronary interventions) in 71 cases (37%) with
the lead cover over the patient (group 1) and in 118 cases (63%) without it (group
2). Fluoroscopy times, dose area products and ambient irradiation were similar
with and without the lead cover (4 ± 2 vs 4.1 ± 0.6 min, 55,7 ± 5,8 vs 57,6 ± 4,2
Gy cm2 and 0.7 ± 0.2 vs 0.8 ± 0.1 μSv respectively – p > 0.05). However, operator
irradiation was markedly decreased by using the lead cover: from 19.2 ± 3.1 to 4.9
± 0.9 μSv at the chest level (p=0,001), from 1.8 ± 0.3 to 0.3 ± 0.1 μSv at the back
(p=0.002) and from 25.8 ± 4.7 to 10.2 ± 2.2 μSv at the left arm (p=0,019).
Conclusions: Using a lead cover placed over the patient is highly effective
in attenuating operator scatter radiation exposure during coronary procedure.
Such additional protection device might be useful either in the perspective of
long duration procedure or in routine use.
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Prognostic impact of arterial access site in PCI for acute coronary
syndromes
Elodie Blicq, Gerard Pacouret, Laurent Quilliet, Bernard Desveaux, Ber-
nard Charbonnier, Axel De Labriolle
Hopital trousseau, cardiologie, Tours Cedex 9, France
Background: Percutaneous coronary intervention (PCI) is the cornerstone of
revascularization in acute coronary syndromes (ACS). The radial artery cathete-
